Rimonabant improves obesity but not the overall cardiovascular risk and quality of life; results from CARDIO-REDUSE (CArdiometabolic Risk reDuctIOn by Rimonabant: the Effectiveness in Daily practice and its USE)

Jolien E. J. Boesten; Janneke Kaper; Henri E. J. H. Stoffers; Abraham A. Kroon; Onno C. P. van Schayck

doi:10.1093/fampra/cms013

Rimonabant improves obesity but not the overall cardiovascular risk and quality of life; results from CARDIO-REDUSE (CArdiometabolic Risk reDuctIOn by Rimonabant: the Effectiveness in Daily practice and its USE)

Jolien E. J. Boesten, Janneke Kaper, Henri E. J. H. Stoffers, Abraham A. Kroon, Onno C. P. van Schayck

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	521-527
Journal	Family Practice
Volume	29
Issue number	5
DOIs	https://doi.org/10.1093/fampra/cms013
Publication status	Published - Oct 2012

Keywords

Atherosclerosis
cardiovascular disorders
diabetes
drug reactions
hypertension
insulin resistance
pharmacology
primary care
quality of life

Access to Document

10.1093/fampra/cms013

Cite this

Boesten, J. E. J., Kaper, J., Stoffers, H. E. J. H., Kroon, A. A., & van Schayck, O. C. P. (2012). Rimonabant improves obesity but not the overall cardiovascular risk and quality of life; results from CARDIO-REDUSE (CArdiometabolic Risk reDuctIOn by Rimonabant: the Effectiveness in Daily practice and its USE). Family Practice, 29(5), 521-527. https://doi.org/10.1093/fampra/cms013

Boesten, Jolien E. J. ; Kaper, Janneke ; Stoffers, Henri E. J. H. ; Kroon, Abraham A. ; van Schayck, Onno C. P. / Rimonabant improves obesity but not the overall cardiovascular risk and quality of life; results from CARDIO-REDUSE (CArdiometabolic Risk reDuctIOn by Rimonabant: the Effectiveness in Daily practice and its USE). In: Family Practice. 2012 ; Vol. 29, No. 5. pp. 521-527.

@article{bb29559dc90e477c83e6cde65fc1f8b8,

title = "Rimonabant improves obesity but not the overall cardiovascular risk and quality of life; results from CARDIO-REDUSE (CArdiometabolic Risk reDuctIOn by Rimonabant: the Effectiveness in Daily practice and its USE)",

keywords = "Atherosclerosis, cardiovascular disorders, diabetes, drug reactions, hypertension, insulin resistance, pharmacology, primary care, quality of life",

author = "Boesten, {Jolien E. J.} and Janneke Kaper and Stoffers, {Henri E. J. H.} and Kroon, {Abraham A.} and {van Schayck}, {Onno C. P.}",

year = "2012",

month = oct,

doi = "10.1093/fampra/cms013",

language = "English",

volume = "29",

pages = "521--527",

journal = "Family Practice",

issn = "0263-2136",

publisher = "Oxford University Press",

number = "5",

}

Boesten, JEJ, Kaper, J, Stoffers, HEJH, Kroon, AA & van Schayck, OCP 2012, 'Rimonabant improves obesity but not the overall cardiovascular risk and quality of life; results from CARDIO-REDUSE (CArdiometabolic Risk reDuctIOn by Rimonabant: the Effectiveness in Daily practice and its USE)', Family Practice, vol. 29, no. 5, pp. 521-527. https://doi.org/10.1093/fampra/cms013

Rimonabant improves obesity but not the overall cardiovascular risk and quality of life; results from CARDIO-REDUSE (CArdiometabolic Risk reDuctIOn by Rimonabant: the Effectiveness in Daily practice and its USE). / Boesten, Jolien E. J.; Kaper, Janneke; Stoffers, Henri E. J. H.; Kroon, Abraham A.; van Schayck, Onno C. P.

In: Family Practice, Vol. 29, No. 5, 10.2012, p. 521-527.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Rimonabant improves obesity but not the overall cardiovascular risk and quality of life; results from CARDIO-REDUSE (CArdiometabolic Risk reDuctIOn by Rimonabant: the Effectiveness in Daily practice and its USE)

AU - Boesten, Jolien E. J.

AU - Kaper, Janneke

AU - Stoffers, Henri E. J. H.

AU - Kroon, Abraham A.

AU - van Schayck, Onno C. P.

PY - 2012/10

Y1 - 2012/10

KW - Atherosclerosis

KW - cardiovascular disorders

KW - diabetes

KW - drug reactions

KW - hypertension

KW - insulin resistance

KW - pharmacology

KW - primary care

KW - quality of life

U2 - 10.1093/fampra/cms013

DO - 10.1093/fampra/cms013

M3 - Article

VL - 29

SP - 521

EP - 527

JO - Family Practice

JF - Family Practice

SN - 0263-2136

IS - 5

ER -